Skip to content

The role of Intraperitoneal Ropivacaine in Laparoscopic Appendicectomy: A prospective, double blinded randomised control study

The effect of intraperitoneal Ropivacaine on post-laparoscopic pain in appendicectomy patients compared with the effect of intraperitoneal normal saline.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12614001161617
Enrollment
86
Registered
2014-11-04
Start date
2015-04-06
Completion date
2017-08-04
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study investigates the analgesic effect of intraperitoneal injection of a long acting local anaesthetic agent (Ropivacaine) during laparoscopic (keyhole) appendicectomy. Trial participants will be randomly divided into two groups. One group will receive intraperitoneal Ropivacaine during laparoscopic appendicectomy while the other will receive normal saline. The consumption quantity of total Fentanyl analgesia, the presence of shoulder tip pain and post surgery nausea or vomiting will be recorded up to 16 hours post surgery. The study aims to determine whether the use of Ropivacaine during laparoscopic appendectomy is an useful analgesic adjunct. The primary aim of this study will be to determine whether using Ropivacaine will reduce total amount of analgesia used, hence reducing post-operative pain, and its effect on the incidence of post laparoscopic appendicectomy shoulder tip pain and nausea or vomiting.

Interventions

Intraperitoneal injection of 0.5ml per kilogram of 0.2% Ropivacaine after the insertion of suprapubic port and another 0.5ml per kilogram of the same solution at the end of laparoscopic appendicectomy.

Sponsors

Armadale and Kelmscott Memorial Hospital
Lead SponsorHospital

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

All patients undergoing laparoscopic appendicectomy at Armadale Hospital

Exclusion criteria

1. Medical or psychiatric conditions that compromise patient’s ability to give informed consent 2. Pregnant or breast feeding 3. Allergies to paracetamol, fentanyl or ropivacaine. 4. Liver failure 5. Conversion from laparoscopic surgery to open surgery 6. Presence of faecal peritonitis 7. ASA III 8. Iatrogenic perforation 9. Chronic pain syndrome 10. Operative time more than 2 hours. 11. Drain insertion 12. Weight >100kg

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026